Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C7orf26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LGALS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RERG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC22A23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DTX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THEMIS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNDIG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MXRA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MGST1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AEBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPM6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CABLES1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BEST3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPRN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on